Major Pharmaceutical Firms Receive FDA Warning Letters Amid Drug Advertising Crackdown
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 17 2025
0mins
Source: Yahoo Finance
FDA's Enforcement on Drug Advertisements: The FDA has initiated a crackdown on misleading drug advertisements, sending thousands of warning letters to pharmaceutical companies for unlawful marketing practices, including the sale of unapproved drugs and false claims.
Companies Targeted: Notable companies like Hims & Hers, Eli Lilly, and Novo Nordisk received warnings for various violations, including misleading advertisements related to weight-loss drugs and overstated effectiveness in DTC ads.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
